Alphamab Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	968	419	742	1,218	1,437	1,605
Market Cap Growth	153.10%	-43.55%	-39.08%	-15.24%	-10.46%	11.71%
Enterprise Value	805	268	580	1,052	1,219	1,347
Last Close Price	0.97	0.44	0.75	-	-	-
PE Ratio	34.97	19.03	-	-	-	-
PS Ratio	10.36	4.95	26.58	53.81	71.10	-
PB Ratio	4.39	1.73	3.48	5.76	5.55	5.64
P/TBV Ratio	4.39	1.73	3.48	5.76	5.55	5.64
P/FCF Ratio	37.42	16.61	-	-	-	-
P/OCF Ratio	31.75	14.91	-	-	-	-
EV/Sales Ratio	8.60	3.16	20.76	46.46	60.34	-
EV/EBITDA Ratio	26.06	12.24	-	-	-	-
EV/EBIT Ratio	35.95	20.04	-	-	-	-
EV/FCF Ratio	31.11	10.62	-	-	-	-
Debt / Equity Ratio	0.15	0.10	0.15	0.22	0.34	0.10
Debt / EBITDA Ratio	1.05	1.04	-	-	-	-
Debt / FCF Ratio	1.26	0.98	-	-	-	-
Net Debt / Equity Ratio	-0.74	-0.76	-0.69	-0.64	-0.72	-0.81
Net Debt / EBITDA Ratio	-5.45	-8.38	4.30	2.57	3.48	4.72
Net Debt / FCF Ratio	-6.30	-7.27	4.81	2.34	2.82	4.20
Asset Turnover	0.35	0.29	0.10	0.07	0.06	-
Inventory Turnover	0.83	0.75	0.77	0.72	0.06	-
Quick Ratio	4.76	6.41	5.55	3.72	3.22	6.52
Current Ratio	4.98	6.74	5.84	3.88	3.32	6.67
Return on Equity (ROE)	13.37%	9.49%	-13.04%	-19.00%	-19.91%	-18.21%
Return on Assets (ROA)	5.22%	2.88%	-9.50%	-11.21%	-9.72%	-9.32%
Return on Capital Employed (ROCE)	9.40%	5.10%	-17.30%	-25.00%	-20.10%	-17.70%
Earnings Yield	2.86%	5.25%	-3.62%	-3.63%	-3.97%	-3.34%
FCF Yield	2.67%	6.02%	-4.11%	-4.79%	-4.61%	-3.42%
Buyback Yield / Dilution	-3.37%	-2.53%	-2.50%	-0.11%	-0.62%	-73.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.